Christopher S Lathan
Affiliation: Harvard University
- Racial composition of hospitals: effects on surgery for early-stage non-small-cell lung cancerChristopher S Lathan
Department of Medical Oncology, Division of Population Sciences, Center for Outcomes and Policy Research, Dana Farber Cancer Institute, Boston, MA 02115, USA
J Clin Oncol 26:4347-52. 2008..Our study examines the relationship between the percentage of black patients treated at a hospital to determine whether it affects the likelihood of obtaining cancer-directed surgery for patients with non-small-cell lung cancer (NSCLC)...
- Racial differences in the perception of lung cancer: the 2005 Health Information National Trends SurveyChristopher S Lathan
Division of Population Sciences, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
Cancer 116:1981-6. 2010..Racial disparities in lung cancer have been described well in the literature; however, little is known about perceptions of lung cancer in the general population and whether these perceptions differ by race...
- The effect of race on invasive staging and surgery in non-small-cell lung cancerChristopher S Lathan
Division of Population Sciences, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
J Clin Oncol 24:413-8. 2006..To isolate the effect of decision making from access to care, we used receipt of surgical staging as a proxy for access and willingness to undergo invasive procedures, and examined treatments and outcomes by race...
- Racial differences in prostate cancer screening by family historyBettina F Drake
Department of Society, Human Development and Health, Center for Community Based Research, Harvard School of Public Health, Boston, MA, USA
Ann Epidemiol 18:579-83. 2008..Therefore we examined racial variation in the association of family history of CaP and self-reported prostate-specific antigen (PSA) testing in the nationally-representative National Health Interview Survey (NHIS)...
- Attitudes of patients with cancer about personalized medicine and somatic genetic testingStacy W Gray
Center for Population Sciences, Department of Medical Oncology, Dana Farber Cancer Institute, 450 Brookline Ave, LW 633, Boston, MA 02215, USA
J Oncol Pract 8:329-35, 2 p following 335. 2012..Dramatic advances in genomic technology stand to revolutionize cancer care; however, little is known about patients' understanding and acceptance of personalized medicine and widespread genetic testing (GT)...
- Religiousness and spiritual support among advanced cancer patients and associations with end-of-life treatment preferences and quality of lifeTracy A Balboni
Harvard Radiation Oncology Program, Dana Farber Cancer Institute, Boston, MA, USA
J Clin Oncol 25:555-60. 2007..This study examined religiousness and spiritual support in advanced cancer patients of diverse racial/ethnic backgrounds and associations with quality of life (QOL), treatment preferences, and advance care planning...
- Utilization of epidermal growth factor receptor (EGFR) testing in the United States: a case study of T3 translational researchJulie A Lynch
Veterans Health Administration, University of Massachusetts Boston and Dana Farber Cancer Institute, Boston, MA, USA
Genet Med 15:630-8. 2013..Our goal was to inform the development of a model to predict phase 3 translation of guideline-directed molecular diagnostic tests...
- Integrating multiple social statuses in health disparities research: the case of lung cancerDavid R Williams
Department of Society, Human Development and Health, Harvard University, School of Public Health, 677 Huntington Avenue, 6th Floor, Boston, MA, 02215, USA
Health Serv Res 47:1255-77. 2012....
- Racial disparities in the treatment of lung cancer in African AmericansChristopher Lathan; Fiscal Year: 2007..The education plan, in conjunction with the research projects would give the candidate the training and tools to be a leading researcher in the disparities field. ..